1,4-Dioxane → HCID 117737169, compound
Reaction equation
[NH2:1][C:2]1[CH:6]=[CH:5][O:4][N:3]=1.[Br:7][C:8]1[C:13]([Cl:14])=[CH:12][C:11]([N:15]2[C:24]3[C:19](=[CH:20][C:21]([S:25](Cl)(=[O:27])=[O:26])=[CH:22][CH:23]=3)[C:18]([CH3:29])=[CH:17][C:16]2=[O:30])=[C:10]([O:31][CH3:32])[CH:9]=1.[Li+].C[Si]([N-][Si](C)(C)C)(C)C.O1CCOCC1>C1COCC1>[Br:7][C:8]1[C:13]([Cl:14])=[CH:12][C:11]([N:15]2[C:24]3[C:19](=[CH:20][C:21]([S:25]([NH:1][C:2]4[CH:6]=[CH:5][O:4][N:3]=4)(=[O:26])=[O:27])=[CH:22][CH:23]=3)[C:18]([CH3:29])=[CH:17][C:16]2=[O:30])=[C:10]([O:31][CH3:32])[CH:9]=1Participants
Procedure
A solution of 3-aminoisoxazole (0.867 ml, 11.74 mmol) and 1-(4-bromo-5-chloro-2-methoxyphenyl)-4-methyl-2-oxo-1,2-dihydroquinoline-6-sulfonyl chloride (1.120 g, 2.347 mmol) in 10 mL THF, was cooled to 0° C. LHMDS 1N in THF (11.74 ml, 11.74 mmol) was added, and the cooling bath was removed. After stirring for an additional hour, the reaction mixture was treated with hcl 4N in dioxane (5.87 ml, 23.47 mmol) and was concentrated. Purification of the crude residue by reverse phase column chromatography [Redisep Gold C18, 10-100% (0.1% NH4OH in MeOH)/(0.1% NH4OH in water)] gave 1-(4-bromo-5-chloro-2-methoxyphenyl)-N-(isoxazol-3-yl)-4-methyl-2-oxo-1,2-dihydroquinoline-6-sulfonamide (0.307 g, 0.585 mmol, 24.92% yield). In/z (ESI) 525.9 (M+H)+.
Workup
- customthe cooling bath was removed
- concentrationwas concentrated
- customPurification of the crude residue by reverse phase column chromatography [Redisep Gold C18, 10-100% (0.1% NH4OH in MeOH)/(0.1% NH4OH in water)]
Sources & evidence
- ORD record
- ord-d3c112d5b90c4a0baa12bf5b8a14fbc0
- Source dataset
- uspto-grants-2015_12
- Patent number
- US09212182B2
Reaction notes
Loading…